Search

everythinglearnresearchcommunity

for

Search:↓

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Stilbamidine and hydroxystilbamidine inhibit enzyme release from lysosomes and have effects similar to cortisol and chloroquine.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Vemurafenib causes significant skin side effects, requiring regular dermatologist care and sun protection.

Certain drugs that block specific enzymes can help treat prostate diseases.

The composition with carnitine, thioctic acid, and saw palmetto extract may effectively reduce inflammation in hair follicle cells.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Cubosomal gels enhance skin absorption of cetirizine better than niosomal gels.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Keratin-based hydrogels with calcium are effective for delivering anti-fibrotic drugs.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Vitamin D protects skin cells from damage caused by captopril.

Enzyme injections can effectively treat epidermoid cysts without surgery.

New molecules can prevent cell death in hair follicles.

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

A peptide known for reducing wrinkles also effectively inhibits an enzyme linked to skin inflammation and acne.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.